Azelis to Add Localpack in Colombia

Acquisition
Azelis strengthened its footprint in Latin America with the agreement to acquire Localpack S.A., a specialty chemical distributor active in both the life sciences and industrial chemicals segments in Colombia. The acquisition represents a strategic expansion of the group’s footprint, consistent with its growth objectives in the region. Localpack is one of the leading specialty chemical distributors in the domestic market. The company employs a staff of 27 people, and operates an application laboratory close to Medellin, serving customers across Colombia. Localpack’s long-standing relationships with global and regional principals, and the technical product expertise that it has built over the years, expand Azelis’ lateral value chain across Latin America. This expansion will allow Azelis to serve customers better and accelerate its growth in the region. “The acquisition of Localpack brings Azelis a partner with a strong product portfolio and performance track record in Colombia,” said Todd Cottrell, CEO, Azelis Americas. “This transaction expands our customer base and relationships with key principal partners who are aligned with our strategic vision for the region. The Localpack team shares our commitment to innovation, and we look forward to continuing towards our goal of becoming the preeminent provider of innovation and solutions for our customers and principals in Latin America.”
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Organizations
Indications
-
Targets
-
Drugs
-
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.